TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Oncology

• Publication date

  2010-12-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3892/IJO-00000845PMID 21109947PMCID PMC3004145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

  2010cited by this paper
• c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.

  2010cited by this paper
• Signal integration by JNK and p38 MAPK pathways in cancer development

  2009cited by this paper
• Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis

  2008cited by this paper
• Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily.

  2008cited by this paper
• Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!

  2008cited by this paper
• p38alpha: a suppressor of cell proliferation and tumorigenesis.

  2007cited by this paper
• p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells

  2007cited by this paper
• Evidence for Two Modes of Development of Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance

  2007cited by this paper
• PTHrP‐induced MCP‐1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro

  2007cited by this paper
• p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.

  2007cited by this paper
• alpha-Tocopheryl succinate-induced apoptosis in human gastric cancer cells is modulated by ERK1/2 and c-Jun N-terminal kinase in a biphasic manner.

  2007cited by this paper
• Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.

  2007cited by this paper
• P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells

  2006cited by this paper
• MAPK-activated Protein Kinase-2 (MK2)-mediated Formation and Phosphorylation-regulated Dissociation of the Signal Complex Consisting of p38, MK2, Akt, and Hsp27*

  2006cited by this paper
• p38 MAPK in Development and Cancer

  2006cited by this paper
• TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma

  2006cited by this paper
• P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.

  2006cited by this paper
• Opposing Roles for ERK1/2 in Neuronal Oxidative Toxicity

  2006cited by this paper
• Monocyte chemotactic protein‐1 (MCP‐1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion

  2006cited by this paper
• MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer

  2006cited by this paper
• PI-3K/Akt and NF-kappaB/IkappaBalpha pathways are activated in Jurkat T cells in response to TRAIL treatment.

  2005cited by this paper
• Mechanisms of resistance to TRAIL-induced apoptosis in cancer

  2005cited by this paper
• Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1–MEK–JNK signal transduction pathway during metabolic oxidative stress

  2005cited by this paper
• Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt*

  2005cited by this paper
• Role of JNK activation in apoptosis: A double-edged sword

  2005cited by this paper
• Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand*

  2005cited by this paper
• PI‐3K/Akt and NF‐κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatment

  2005cited by this paper
• Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicity.

  2004cited by this paper
• Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

  2004cited by this paper
• TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells

  2004cited by this paper
• Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells*

  2003cited by this paper
• Size matters: of the small HSP27 and its large oligomers

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Protein kinase B (PKB/Akt) – a key regulator of glucose transport?

  2001cited by this paper
• Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1.

  2001cited by this paper
• Expression of collagenase‐3 (matrix metalloproteinase‐13) in transitional‐cell carcinoma of the urinary bladder

  2000cited by this paper
• Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.

  2000cited by this paper
• Interstitial collagenases as markers of tumor progression.

  2000cited by this paper
• Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

  1999cited by this paper
• Direct control of the Forkhead transcription factor AFX by protein kinase B

  1999cited by this paper
• Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

  1999cited by this paper
• Regulation of Hsp27 Oligomerization, Chaperone Function, and Protective Activity against Oxidative Stress/Tumor Necrosis Factor α by Phosphorylation*

  1999cited by this paper
• Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor.

  1998cited by this paper
• Early Activation of c-Jun N-terminal Kinase and p38 Kinase Regulate Cell Survival in Response to Tumor Necrosis Factor α*

  1998cited by this paper
• Regulation of cell death protease caspase-9 by phosphorylation.

  1998cited by this paper
• Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway*

  1998cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper
• Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.

  1994cited by this paper
• Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.

  1994cited by this paper
• Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins

  1992cited by this paper

• La inactivación de Pim quinasas potencia la muerte celular mediada por el ligando de muerte trail en glioblastoma

  2019influential citation
• From Oxidative Stress Damage to Pathways, Networks, and Autophagy via MicroRNAs

  2018cites this paper
• University of Groningen Trail receptor-targeted therapy : strategies to enhance DR 4-and DR 5-induced apoptosis

  2017cites this paper
• Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation

  2016cites this paper
• Trail receptor-targeted therapy : strategies to enhance DR4- and DR5-induced apoptosis

  2014cites this paper
• HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt/ERK signaling through interaction with β-arrestin2.

  2014cites this paper
• Modeling Dynamics of Cell-to-Cell Variability in TRAIL-Induced Apoptosis Explains Fractional Killing and Predicts Reversible Resistance

  2014cites this paper
• TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.

  2013cites this paper
• Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family

  2013cites this paper
• Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes

  2013cites this paper
• TRAIL-induced kinases activation and apoptosis: towards improved death receptor targeted therapy for lung cancer

  2013cites this paper
• HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL.

  2012cites this paper
• A class IA PI3K controls inflammatory cytokine production in human neutrophils

  2011cites this paper